Gene: SESTD1
Official Full Name: SEC14 and spectrin domain containing 1provided by HGNC
Gene Summary: Enables phosphatidylinositol-3,4-bisphosphate binding activity and phospholipid binding activity. Involved in negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel. Located in calcium channel complex and intermediate filament cytoskeleton. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23488 | SESTD1 Knockout cell line (HeLa) | Human | SESTD1 | 1:3~1:6 | Negative | Online Inquiry |
KO23489 | SESTD1 Knockout cell line (HCT 116) | Human | SESTD1 | 1:2~1:4 | Negative | Online Inquiry |
KO23490 | SESTD1 Knockout cell line (HEK293) | Human | SESTD1 | 1:3~1:6 | Negative | Online Inquiry |
KO23491 | SESTD1 Knockout cell line (A549) | Human | SESTD1 | 1:3~1:4 | Negative | Online Inquiry |
SESTD1 Gene Knockout Cell Lines represent a cutting-edge tool in the field of genetic research and cellular biology, specifically designed to elucidate the functions and pathways associated with the SESTD1 gene. These cell lines are engineered to lack the SESTD1 gene, allowing researchers to investigate the gene's role in various physiological and pathological processes by comparing knockout cells with wild-type controls. The unique functionality of these cell lines lies in their ability to mimic the effects of loss-of-function mutations, facilitating studies on cellular mechanisms, signal transduction, and interactions within the cellular environment.
The mechanisms by which SESTD1 operates are crucial for understanding its role in cellular dynamics, particularly in areas such as cell growth, proliferation, and differentiation. In both research and clinical settings, these knockout cell lines provide invaluable insights into diseases associated with SESTD1, potentially leading to discoveries of novel therapeutic targets and applications in regenerative medicine.
One of the significant advantages of using SESTD1 Gene Knockout Cell Lines over alternative models is their specificity and ease of use. While traditional methods, such as CRISPR-Cas9, require a complex design and validation process, these pre-established knockout cell lines provide ready-to-use models that save researchers time and resources, allowing for rapid experimental setup. Additionally, they are rigorously characterized, ensuring robust and reproducible results.
This product is especially valuable to researchers and clinicians seeking to deepen their understanding of genetic pathways and the functional impacts of gene loss, powering advancements in personalized medicine and targeted therapies.
As a company with a proven track record in the development of high-quality biological tools, we are committed to advancing scientific discovery by providing innovative products such as the SESTD1 Gene Knockout Cell Lines. Our expertise ensures that researchers have access to reliable and effective resources, pushing the boundaries of genetic research to new heights.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.